• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL G4 STEERABLE GUIDING CATHETER; CATHETER, STEERABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL G4 STEERABLE GUIDING CATHETER; CATHETER, STEERABLE Back to Search Results
Catalog Number SGC0702
Device Problem Difficult to Insert (1316)
Patient Problems Cardiac Arrest (1762); Hemorrhage/Bleeding (1888); Perforation of Vessels (2135); Cardiogenic Shock (2262)
Event Date 03/22/2023
Event Type  Death  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
This is filed to report a perforation, bleeding, cardiac arrest and death.It was reported that a mitraclip procedure was performed to treat functional mitral regurgitation (mr).The patient was hypotensive at the start of the procedure and this led to arrhythmias.This was resolved by cardiopulmonary resuscitation (cpr) immediately after the intubation of the patient.After a successful transseptal puncture, the femoral vein was pre-dilated before the steerable guide catheter (sgc) insertion because of fibrotic tissue at the groin site due to patient's pre-existing peripheral arterial disease.The sgc was inserted into the femoral vein about 10 to 15cm before encountering blockage/resistance.The physician looked at fluoro with contrast and noticed a perforation in the femoral vein.Two stents were placed to try and stop the bleeding but were unsuccessful.A vascular surgeon was called in and two stentgrafts were placed which stopped the bleeding.However, during the bleeding the patient remained hypotensive which led to several cardiac arrests each time requiring cpr.After performing about 45 minutes of cpr the patient went into cardiogenic shock which led to the death of the patient.The physician is unsure what caused the perforation, but it is thought the sgc worsened the perforation.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other complaints reported from this lot.Based on all available information, the reported difficult sgc insertion appears to be due to challenging patient anatomy.The reported vein perforation, hemorrhage, cardiac arrest, cardiogenic shock, and death appear to be cascading events of the difficult sgc insertion.Additionally, vessel perforation, cardiac arrest, hemorrhage, and cardiogenic shock are listed in the instructions for use (ifu) as known potential complications associated with mitraclip procedures.The reported unexpected medical interventions (cpr, stent placements) are the results of case-specific circumstances.There is no indication of product issue with respect to manufacture, design or labeling.In addition, the event was reviewed by an abbott senior director of medical affairs.The reviewer stated, ¿the femoral vein injury was the result of femoral vein access with manipulation of wires, catheters and the steerable guide catheter.This patient appeared to be a high-risk patient that had arrythmia issues and required cpr from general intubation.It is unsure when this femoral vein tear occurred but became relevant as the steerable guide was being introduced into the femoral vein.The cascade of events which led to the patient¿s death seemed to start at the time of intubation and anesthesia induction and were exacerbated by femoral vein rupture and associated significant bleeding.The femoral vein injury was likely due to the insertion of the sgc into a groin with challenging anatomy (fibrosis as documented).While efforts to repair the perforation were successful but the patient¿s condition had declined significantly throughout this time and progressed into cardiogenic shock and eventually ending with the patient expiring.¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G4 STEERABLE GUIDING CATHETER
Type of Device
CATHETER, STEERABLE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key16752341
MDR Text Key313419837
Report Number2135147-2023-01676
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
K190167
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/17/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/18/2023
Device Catalogue NumberSGC0702
Device Lot Number21219R1116
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/28/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/19/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-